ArticleNeuro-oncology2023

The development of a rapid patient-derived xenograft model to predict chemotherapeutic drug sensitivity/resistance in malignant glial tumors.

Martine Charbonneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.